Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

S Korean Stem Cell Firm Enters Into an Agreement with Tiantan Puhua Hospital in China

RNL Bio entered into an agreement with Tiantan Puhua Hospital for stem cell treatments for complications including spinal cord injury, hair loss and osteoarthritis.

Rockville, MD (PRWEB) February 6, 2008 -- RNL Bio, Co., LTD., (RNL), a leading stem cell therapeutics company of Korea, on Feb 4, 2008, has entered into an agreement with Beijing Tiantan Puhua Hospital (Puhua) in Beijing, China to establish a joint venture (the firm) and a new hospital to provide patients with stem cell therapeutics.

Dr. Sherwood Yang, Vice president of Puhua agreed with Dr. Jeong Chan Ra, president of CEO of RNL, to open a new stem cell clinic within Puhua hospital through the firm. The new hospital was tentatively named as "RNL-Puhua Stem Cell Medical Center, and will provide stem cell treatments of various degenerative disease including hair loss, aged face and osteoarthritis. The firm will also supply Puhua hospital with stem cell therapeutics for neurological condition such as spinal cord injury which Puhua is specialized for.

"We are very pleased to have a new hospital for stem cell therapy in China. It will not only advance the commercialization of out stem cell technology but contribute effective stem cell treatment to patients with obsolete complications", said Dr. Ra.

About RNL Bio, CO., LTD.

RNL is a premier biotechnology company in Korea focused on stem cell therapeutics and life sciences technologies. Headquartered in Seoul with a recently opened state-of-the-art GMP facility, RNL is a publicly traded company on the Korean Stock Exchange (Code 003190) and strives to become a global leader in the development of stem cell therapeutics. In 2006 RNL established wholly owned US subsidiary, RNL Biostar, for clinical development in the US and for licensing its technologies in North and South America.

About Beijing Tiantan Puhua Hospital

Tiantan (Temple of Heaven) Puhua (treasure) Hospital is a world-class neurological treatment facility in Beijing that is gaining renown as the world's foremost center for treatment of Parkinson's disease, brain injury, and a range of other neurological disorders through its groundbreaking stem cell therapy. To date, Tiantan Puhua Hospital has treated with stem cells over 60 international patients suffering from a range of neurological disorders.

###

Simillar Articles

International Society for Stem Cell Research Highlights New YouTube Channel Providing Accurate...
The International Society for Stem Cell Research (ISSCR) commends the recent launch of a YouTube channel created by the University of Michigan and designed to share advances in stem cell science....
Stem Cells -- Sorting Through the Hype and Hope
MayoClinic.com offers facts on stem cells.
Progress after Adult Stem Cell Therapy Offers New Hope to Iowa Spinal Cord Injury Patient
Rich Welsh, a 28 year-old insurance agent from Klemme, Iowa who suffered a spinal cord injury after an automobile accident in 1999, is now on the road to recovery after stem cell therapy in...
Americans for Cures Foundation Announces Conference for Stem Cell Advocates: Americans for...
Stem cell research advocates nationwide will gather at the State of Stem Cell Advocacy 2008 conference on April 12-13, 2008. The conference is being presented by Americans for Cures Foundation...
New Site Launched for Families and Scientists to Discuss Stem Cell Research (US)
SickKids Foundation has launched Connecting for Kids: Campaign 2008, a community of researchers, families and people passionate about stem cell and other innovative types of research.
Home Terms of Use Privacy Policy Contact Us